Efficacy and safety of eosinophil-depleting therapy with Benralizumab in chronic eosinophilic pneumonia - Vienna 2024

Clinical translation in rare interstitial lung diseases

Chair(s): Claudia Valenzuela, Marissa O'Callaghan

Session type: Poster session

Efficacy and safety of eosinophil-depleting therapy with Benralizumab in chronic eosinophilic pneumonia

Filippo Gozzi

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study

Wangji Zhou

Poster

Abstract

Impulse oscillometry in the diagnosis of subclinical obstructive airways disease in Osteogenesis Imperfecta

Louise Byrne

Poster

Abstract

Late Breaking Abstract - Tankyrase inhibition demonstrates anti-fibrotic effects in vitro, ex vivo, and in vivo in preclinical pulmonary fibrosis models

Jo Waaler

Poster

Abstract

Nintedanib in Progressive Fibrosing Interstitial Lung Disease (PFILD): Assessing Renal Function Trends and Tolerability

Janet Johnston

Poster

Abstract

Circulating human myeloid cells assume a profibrotic and tissue migratory-prone phenotype in Idiopathic pulmonary fibrosis

Dmytro Sirokha

Poster

Abstract

Efficacy and safety of eosinophil-depleting therapy with Benralizumab in chronic eosinophilic pneumonia

Filippo Gozzi

Poster

Abstract

Immunodeficiencies in childhood interstitial lung diseases: First data from the Turkish National chILD registry

Handan Keke

Poster

Abstract

Novel lamp3 gene mutation associated with variable clinical presentation of interstitial lung disease

Mohamad Hadhud

Poster

Abstract

Renal angiomyolipoma and lymphangiomleiomyoma sirolimus treatment in patients with lymphangioleiomyomatosis .

El?bieta Radzikowska

Poster

Abstract

Cystic Lung Disease in Older Patients with Birt-Hogg-Dubé Syndrome

Vasilios Tzilas

Poster

Abstract

Revitalizing Alveolar Immunity: MSC role in Autoimmune Pulmonary Alveolar Proteinosis

Xinyu Song

Poster

Abstract

Lipoid pneumonitis: new insights - a systematic review

Elisabeth Bendstrup

Poster

Abstract

35 years of the Italian cohort of Pulmonary Alveolar Proteinosis (PAP)

Sara Lettieri

Poster

Abstract

Impact of genetic multidisciplinary team discussion on lung fibrosis

Giovanni Franco

Poster

Abstract

Clinical relevance of diffusing lung capacity for carbon monoxide (DLCO) in patients with acid sphingomyelinase disease (ASMD): a post-hoc analysis

Wim A. Wuyts

Poster

Abstract

Reality check the low positive predictive value of positive autoimmune markers in CTD ILD/myositis

Wint Wah Soe

Poster

Abstract

Trends in pulmonary function in patients with Birt-Hogg-Dubé syndrome: A retrospective cohort study

Jesper R?mhild Davidsen

Poster

Abstract

Quantitative assessment of CT lung abnormalities in cystic pulmonary Langerhans cell histiocytosis using parametric response mapping

Amira Benattia

Poster

Abstract

Role of genetic testing in pleuroparenchymal fibroelastosis

Joelle Friesen

Poster

Abstract

Late Breaking Abstract - New imaging approach to evaluate the in vivo administration of nanostructured mycophenolic acid in a preclinical model of SSC-ILD

Beatrice Ragnoli

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}